Education:

• Ph.D., Institute of Molecular and Cellular Biology, National Taiwan University

Areas of Expertise:

• Drug Development Process
• Preclinical Trials and Translational Medicine Research
• Project Management

Profile:
    Dr. Chang brings over 15 years of hands-on laboratory experience and nearly a decade of experience in new drug development. He previously served as a postdoctoral researcher at the Institute of Cellular and Organismic Biology, Academia Sinica, and as a Senior Research Scientist at Foresee Pharmaceuticals(6576).
    During his tenure at Foresee Pharmaceuticals, he led a comprehensive small-molecule drug screening initiative. He was also responsible for developing and optimizing drug screening and detection methods, and conducted cell-based mechanism-of-action assays that advanced a candidate into Phase II clinical trials of a rare disease.
    Combining his knowledge of drug development with his professional expertise as a certified Project Management Professional (PMP), Dr. Chang is well-positioned to drive the advancement of Eiromics' promising drug development projects.